CAPS Rating

CheapHessian (< 20)

Results 1 - 20 of 45 : 1 2 3 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
17/03/2014 FNV.US 3 out of 5 Outperform 5Y $52.01 $52.99 (+0.32%) +1.88% +7.22% -5.33
17/03/2014 TGD.US 1 out of 5 Outperform 5Y $1.70 $1.50 (+5.63%) -11.76% +7.22% -18.98
17/03/2014 GDXJ.US 3 out of 5 Outperform 5Y $44.33 $38.54 (+2.80%) -13.06% +7.22% -20.28
17/03/2014 LODE.US 1 out of 5 Outperform 5Y $1.94 $1.39 (-1.42%) -28.35% +7.22% -35.57
17/03/2014 AEM.US 3 out of 5 Outperform 5Y $34.20 $34.23 (+0.74%) +0.08% +7.22% -7.14
17/03/2014 ANV.US 2 out of 5 Outperform 5Y $6.37 $3.60 (+1.98%) -43.49% +7.22% -50.70
17/03/2014 GG.US 3 out of 5 Outperform 5Y $28.23 $25.21 (+0.36%) -10.71% +7.22% -17.93
29/02/2012 16/03/2014 AMZN.US 3 out of 5 Underperform 3Y $179.70 $323.89 (-2.20%) +80.24% +44.88% -35.36
26/02/2013 EXK.US 3 out of 5 Outperform 5Y $6.21 $5.04 (+3.49%) -18.84% +32.90% -51.74
11/02/2013 FSM.US 2 out of 5 Outperform 5Y $4.47 $4.65 (+2.20%) +4.03% +31.13% -27.11
11/02/2013 PAAS.US 3 out of 5 Outperform 5Y $16.32 $12.66 (-0.78%) -22.40% +31.13% -53.54
05/02/2013 RIC.US 2 out of 5 Outperform 5Y $3.20 $2.17 (-0.46%) -32.19% +32.35% -64.53
05/02/2013 AXU.US 4 out of 5 Outperform 5Y $4.58 $0.94 (+3.88%) -79.48% +32.35% -111.82
04/02/2013 SSRI.US 3 out of 5 Outperform 5Y $12.09 $7.42 (-1.07%) -38.63% +32.37% -71.00
04/02/2013 GORO.US 1 out of 5 Outperform 5Y $12.63 $5.71 (+0.88%) -54.80% +32.37% -87.17
24/01/2013 SGSVF.US 2 out of 5 Outperform 5Y $2.51 $0.65 (+1.94%) -74.26% +33.41% -107.67
23/01/2013 NRT.US 3 out of 5 Outperform 1Y $21.76 $21.51 (-0.05%) -1.14% +33.43% -34.57
23/01/2013 POT.US 4 out of 5 Outperform 5Y $39.31 $34.55 (+0.76%) -12.10% +33.43% -45.53
23/01/2013 CPE.US 2 out of 5 Outperform 5Y $5.22 $9.29 (-0.75%) +77.97% +33.43% +44.54
14/01/2013 IAG.US 4 out of 5 Outperform 5Y $10.58 $3.45 (-0.14%) -67.40% +35.46% -102.86
Results 1 - 20 of 45 : : 1 2 3 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.